When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins

BACKGROUND: We examined sponsorship of published cost-effectiveness analyses of statin use for cardiovascular (CV) prevention, and determined whether the funding source is associated with study conclusions. METHODS AND FINDINGS: We searched PubMed/MEDLINE (up to June 2011) to identify cost-effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Catalá-López, Ferrán, Sanfélix-Gimeno, Gabriel, Ridao, Manuel, Peiró, Salvador
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704635/
https://www.ncbi.nlm.nih.gov/pubmed/23861972
http://dx.doi.org/10.1371/journal.pone.0069462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704635/
https://www.ncbi.nlm.nih.gov/pubmed/23861972
http://dx.doi.org/10.1371/journal.pone.0069462

Ejemplares similares